Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.
about
CXCR3 in carcinoma progressionThe multifaceted functions of CXCL10 in cardiovascular diseaseChemokines as mediators of tumor angiogenesis and neovascularizationAngiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.CXC chemokines in cancer angiogenesis and metastasesChemokines as mediators of neovascularizationThe role of CXC chemokines in pulmonary fibrosis.CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapyRoles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity.CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomasInterferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis.Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.The emerging role of CXC chemokines and their receptors in cancer.Chemokine receptor CXCR3 promotes growth of glioma.Association between preeclampsia and the CXC chemokine family (Review).Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosisInsect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors.Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cellsThe chemokine receptors CXCR4 and CXCR3 in cancer.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.The role of CXC chemokines and their receptors in the progression and treatment of tumors.Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation.Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy.Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?A guide to chemokines and their receptors.Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer
P2860
Q26826928-FE8ED710-3620-4A0A-97F3-C27D82C2EF05Q27010051-B9BB8A0F-6A9B-4BAE-A5DE-796A9A2C0D0AQ30427886-2ED432D0-BBEF-4360-925D-DC9527E15C0DQ30428793-397697CE-2746-46AE-9059-4B5212527661Q30432791-A512DB32-7163-472C-A522-C170781781AFQ30438032-F4A33959-D55C-48FA-A628-BACAC1B566A3Q30443091-A7564F5A-FBFB-446D-A0F4-43BACD54BA99Q33552227-6BA7D52F-3BD2-4C83-86EE-A46F46455DF0Q33816250-FB960FD2-B506-434E-8C02-E26CD925D70AQ33816432-5C00B689-2E3E-4494-8360-38E7CB8B8911Q33920086-C440E51D-CB65-433C-9305-1A35394FB529Q34020909-ACFE0942-0D2D-4344-826A-F615D4372199Q34231598-CAABC607-A8DE-47DB-A37F-97F29C042D73Q34263645-B6A2C6F4-2094-4BAE-8482-875790A76FBDQ34520386-265199FF-1994-4BEF-9483-37437E7ECAB4Q35753903-5436D60B-71A8-4BFC-A0FC-19E2284DC529Q36129961-3095B370-9C64-467B-A19D-C6D950616D03Q36279906-0CACF453-ED9E-45AB-98DC-2EA79F79201FQ36985818-F1C6B16B-461A-474A-9BDB-22185E3F104BQ37046628-9F5212C4-F475-46D7-BF6E-09CAAD93F199Q37149868-D39B42AC-7204-4860-BBFF-6412F9FBAB4DQ37393013-2304FC6C-3F60-4AF1-971F-8864E5066522Q37432097-EF20824A-5EA4-49B5-82DB-63F51C728606Q38023245-519680BB-9AE9-4CBB-BB5B-4E5F554D5367Q38994830-79AC56C7-366B-40C8-92B8-12436CA53E39Q39098568-F1F5C1CE-C964-4D1F-AEDC-27A41D1FE9F2Q39501428-BAA7DB26-54C4-47D9-B413-7F0B66F84924Q41628251-C99D26F5-0909-4109-AA47-C01FDC0C66B7Q43500476-3A555172-BBCF-47E0-8B05-F7D76747FD00Q43939710-05C15802-04D6-4674-BD29-A6AC0E5093A6Q44906072-C118F4BD-C79D-468E-92D7-73AF6682887EQ45931583-E250E099-EC6B-49DF-9662-36A395D10DE1Q47880997-1A99CCE3-2858-44FB-B3C9-2FD455D2CE72Q49524220-D10B24F0-ACBC-4AE1-B993-C227AD29188DQ49656814-88EAD320-4A93-41CD-B3EC-01B00DC4A48DQ54238056-7379F8AA-56CF-40E1-ABC3-6C63A3E5DB66Q54618538-09B327E0-3555-44BA-9B66-04F9FC96088FQ57492052-67B3C4D9-4C3E-4568-9147-A5FAC0F01552
P2860
Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification and partial cha ...... transcriptional exon skipping.
@en
type
label
Identification and partial cha ...... transcriptional exon skipping.
@en
prefLabel
Identification and partial cha ...... transcriptional exon skipping.
@en
P2093
P1476
Identification and partial cha ...... transcriptional exon skipping.
@en
P2093
Christina A Addison
Jan Erik Ehlert
Marie D Burdick
Robert M Strieter
Steven L Kunkel
P304
P356
10.4049/JIMMUNOL.173.10.6234
P407
P577
2004-11-01T00:00:00Z